MedTrace Logo

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

NCT06726889 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2024-12-20

No results posted yet for this study

Summary

Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.

Conditions

Interventions

BEHAVIORAL

Standard care

Patient will not receive any additional interventions

BEHAVIORAL

Decision Support System (DSS)

DSS will be used to deliver educational material through a web-page (in Italian language) accessible through a link

BEHAVIORAL

Reminders

Personalized reminders will be delivered to patients through a common messaging application (WhatsApp)

BEHAVIORAL

Feedback

Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Gabriella Pravettoni, MD · European Istitute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-25
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06726889 on ClinicalTrials.gov